XML 42 R30.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholder's Equity (Deficit) - Narrative (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Feb. 19, 2018
Feb. 12, 2018
Jan. 06, 2018
Dec. 14, 2017
Nov. 21, 2017
Aug. 31, 2018
Jul. 31, 2018
May 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Class of Stock [Line Items]                              
Proceeds from initial public offering, net of underwriters fees   $ 56,300,000             $ 67,700,000       $ 67,700,000 $ 0  
Number of shares sold upon completion of follow-on public offering (in shares)             3,600,000                
Sale of stock, offering price (in usd per share)   $ 12.00 $ 12.00     $ 20.00                  
Proceeds from follow-on offering, net of underwriters fees                         $ 56,330,000 0  
Preferred stock, shares authorized (in shares)   10,000,000             10,000,000       10,000,000   10,000,000
Preferred stock, shares issued (in shares)                 0       0   0
Preferred stock, shares outstanding (in shares)                 0       0   0
Preferred stock, par value (in dollars per share)   $ 0.00001             $ 0.00001       $ 0.00001   $ 0.00001
Common stock, shares authorized (in shares)   100,000,000             100,000,000       100,000,000   20,000,000
Common stock, par value (in dollars per share)   $ 0.00001             $ 0.00001       $ 0.00001   $ 0.00001
Common stock, shares, issued (in shares)                 27,274,991       27,274,991   16,527,000
Common stock, shares, outstanding (in shares)                 27,274,991       27,274,991   16,527,000
Contingent royalty obligation payable to Evolus Founders, a related party   $ 40,600,000             $ 51,100,000       $ 51,100,000   $ 0
Contingent promissory note payable to Evolus Founders, a related party   16,100,000             $ 16,791,000       16,791,000   $ 0
Payments on related party borrowings                         (5,000,000) 0  
Capital contribution from parent, forgiveness of related party borrowings                         13,188,000 0  
Maximum number of shares authorized under the plan (in shares)         4,361,291                    
Annual increase percentage of maximum shares outstanding (equal to)         4.00%                    
Options granted (in shares) 102,835   1,496,005           349,240 1,570,145          
Exercise price of options granted (in dollars per share) $ 11.70   $ 9.98           $ 20.55 $ 10.85          
Allocated stock-based compensation expense                 $ 1,482,000     $ 226,000 5,111,000 472,000  
Restricted stock units                              
Class of Stock [Line Items]                              
Options granted (in shares)                 11,000 80,000          
Exercise price of options granted (in dollars per share)     $ 9.98           $ 21.21 $ 26.22          
Equity instruments other than options granted (in shares)     230,516                        
ALPHAEON                              
Class of Stock [Line Items]                              
Allocated stock-based compensation expense                 $ 0       30,000    
Evolus, Inc. | SCH                              
Class of Stock [Line Items]                              
Related party transaction amount in period   $ 56,700,000   $ 20,000,000                      
Chief Executive Officer | Initial issuance                              
Class of Stock [Line Items]                              
Options granted (in shares)               50,112              
Number of shares vested (in shares)               100,424              
Chief Executive Officer | Secondary issuance                              
Class of Stock [Line Items]                              
Number of shares vested (in shares)               50,112              
Chief Executive Officer | ALPHAEON                              
Class of Stock [Line Items]                              
Related party transaction amount in period                         800,000    
General and administrative                              
Class of Stock [Line Items]                              
Allocated stock-based compensation expense                 1,160,000     $ 215,000 $ 4,083,000 $ 447,000  
General and administrative | Chief Executive Officer | Initial issuance                              
Class of Stock [Line Items]                              
Allocated stock-based compensation expense                 $ 1,000,000            
General and administrative | Chief Executive Officer | Secondary issuance                              
Class of Stock [Line Items]                              
Allocated stock-based compensation expense               $ 400,000              
Convertible Preferred Stock                              
Class of Stock [Line Items]                              
Preferred stock, shares authorized (in shares)                 0       0   2,500,000
Preferred stock, shares issued (in shares)                 0       0   1,250,000
Preferred stock, shares outstanding (in shares)                 0       0   1,250,000
Preferred stock, par value (in dollars per share)                 $ 0.00001       $ 0.00001   $ 0.00001
Common Stock                              
Class of Stock [Line Items]                              
Number of shares of convertible preferred stock converted (in shares)   2,065,875                          
Common Stock | Convertible Preferred Stock                              
Class of Stock [Line Items]                              
Number of shares of convertible preferred stock converted (in shares)   2,065,875                          
IPO                              
Class of Stock [Line Items]                              
Number of shares issued in transaction (in shares)   5,047,514                          
IPO | ALPHAEON                              
Class of Stock [Line Items]                              
Payments on related party borrowings                     $ (5,000,000)   $ (5,000,000)    
Underwriters Option                              
Class of Stock [Line Items]                              
Number of shares issued in transaction (in shares)   47,514                          
Number of shares sold upon completion of follow-on public offering (in shares)           600,000